Cargando…
XIAP Antagonist Embelin Inhibited Proliferation of Cholangiocarcinoma Cells
Cholangiocarcinoma cells are dependent on antiapoptotic signaling for survival and resistance to death stimuli. Recent mechanistic studies have revealed that increased cellular expression of the E3 ubiquitin-protein ligase X-linked inhibitor of apoptosis (XIAP) impairs TRAIL- and chemotherapy-induce...
Autores principales: | Wehrkamp, Cody J., Gutwein, Ashley R., Natarajan, Sathish Kumar, Phillippi, Mary Anne, Mott, Justin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946004/ https://www.ncbi.nlm.nih.gov/pubmed/24603802 http://dx.doi.org/10.1371/journal.pone.0090238 |
Ejemplares similares
-
FoxO3 increases miR-34a to cause palmitate-induced cholangiocyte lipoapoptosis
por: Natarajan, Sathish Kumar, et al.
Publicado: (2017) -
Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness
por: Xie, Ying, et al.
Publicado: (2018) -
XIAP inhibitor embelin induces
autophagic and apoptotic cell death in human oral squamous cell carcinoma
cells
por: Lee, You‐Jin, et al.
Publicado: (2017) -
Stress Degradation Studies on Embelin
por: Ferreira, Galvina, et al.
Publicado: (2013) -
The Application of Embelin for Cancer Prevention and Therapy †
por: Ko, Jeong-Hyeon, et al.
Publicado: (2018)